arrow
C

Carmen Tur

Vall d'Hebron Barcelona Hospital Campus
H指数:44
被引数:6,884

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

“Low-Positive” MOG-IgG Cases Among Adults With a First Event Suggestive of Multiple Sclerosis

成人首次发作疑似多发性硬化中“低阳性”MOG-IgG病例

2026-09-030
OAAI
Dorsolateral nigral hyperintensity in idiopathic REM sleep behavior disorder: a systematic review and meta-analysis

特发性快速眼动睡眠行为障碍中背外侧黑质高信号:一项系统评价和Meta分析

2026-08-270
OAAI
A community-validated tool for clinical outcome calculation in multiple sclerosis: Consensus development and scenario-specific recommendations

一种用于多发性硬化症临床结局计算的社区验证工具:共识制定和特定场景建议

2026-08-220
PRE
Spider-MS: an individualized polyhedral prediction of multiple sclerosis prognosis

Spider-MS: 一种针对多发性硬化症预后的个性化多面体预测

Brain
IF11.7
2026-06-100
OAAI
Efficacy and safety of ocrelizumab in primary progressive multiple sclerosis, including older patients and those with more advanced disease (ORATORIO-HAND): a multicentre, double-blind, randomised, placebo-controlled, phase 3b study

奥瑞利珠单抗在原发进展型多发性硬化中的应用效果与安全性,包括老年患者及病情更严重的患者(ORATORIO-HAND):一项多中心、双盲、随机、安慰剂对照的3b期研究

2026-05-280
OAAI
Optic nerve imaging with OCT predicts disease progression and monitors brain and spinal atrophy in primary progressive multiple sclerosis
2026-01-300
PRE
“Effectiveness and associated factors of response to Fampridine in multiple sclerosis: A prospective observational study from an expert center”

“福马林在多发性硬化中的疗效及影响因素:一项来自专业中心的前瞻性观察研究”

2025-11-200
PRE
The Variant rs7665090 Is Associated With Interferon-Beta Response in Multiple Sclerosis Patients

变异体rs7665090与多发性硬化患者干扰素-β反应相关。

2025-07-150
OAAI
The Barcelona baseline risk score to predict long-term prognosis after a first demyelinating event: a prospective observational study

巴塞罗那基线风险评分:预测首次脱髓鞘事件后长期预后的前瞻性观察性研究

2025-06-010
PRE
Personalized treatment decision algorithms for the clinical application of serum neurofilament light chain in multiple sclerosis: A modified Delphi Study

基于血清神经丝轻链在多发性硬化临床应用中的个性化治疗决策算法:一项改良德尔菲研究

2025-04-280
PRE
Deep learning to predict progression independent of relapse activity at a first demyelinating event

深度学习预测首次脱髓鞘事件中独立于复发活动的进展

2025-01-010
PRE
Secondary organising pneumonia associated to COVID-19 infection in patients with central nervous system inflammatory demyelinating diseases treated with anti-CD20 therapies

anti-CD20疗法治疗的中枢神经系统炎性脱髓鞘疾病患者与新型冠状病毒肺炎感染相关的继发性组织肺炎

2024-11-090
PRE